Valuation Biogen Inc. Sao Paulo

Stocks

Market Closed - Sao Paulo 15:31:47 2026-09-21 EDT			5-day change	1st Jan Change
188.28 ^BRL	+0.42%		+0.42%	+16.94%

09-23	AI-based drug developer Basecamp valued at $800 million after $140 million funding round	RE
09-17	Biogen Publishes Phase 3 Pediatric EMPAVELI Data Showing Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3g or Primary IC-MPGN	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	35,242	39,877	37,495	22,283	25,818	33,790	-	-
Change	-	13.15%	-5.97%	-40.57%	15.86%	30.88%	-	-
Enterprise Value (EV) ¹	37,820	40,560	43,384	26,204	28,289	38,727	36,210	33,138
Change	-	7.24%	6.96%	-39.6%	7.96%	36.9%	-6.5%	-8.48%
P/E	23.1x	13.3x	32.5x	13.7x	20x	37.3x	20.2x	16.4x
PBR	3.26x	3.02x	2.53x	1.33x	1.42x	1.83x	1.66x	1.5x
PEG	-	0x	-0.5x	0.3x	-0.9x	-1.2x	0.2x	0.7x
Capitalization / Revenue	3.21x	3.92x	3.81x	2.3x	2.61x	3.24x	3.17x	3.08x
EV / Revenue	3.44x	3.99x	4.41x	2.71x	2.86x	3.71x	3.4x	3.03x
EV / EBITDA	9.13x	11.2x	14.3x	7.1x	7.82x	13.9x	10.4x	9x
EV / EBIT	10.3x	13.1x	17x	8.69x	9.97x	15.4x	11.3x	9.44x
EV / FCF	11.2x	35.5x	34.2x	9.63x	13.8x	20.6x	14.4x	11.6x
FCF Yield	8.94%	2.82%	2.93%	10.4%	7.25%	4.86%	6.94%	8.61%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	10.4	20.87	7.97	11.18	8.79	6.131	11.31	13.94
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	10,982	10,173	9,836	9,676	9,891	10,444	10,658	10,954
EBITDA ¹	4,144	3,618	3,040	3,689	3,618	2,785	3,467	3,683
EBIT ¹	3,656	3,099	2,545	3,015	2,838	2,513	3,208	3,511
Net income ¹	1,556	3,047	1,161	1,632	1,293	996.8	1,859	2,196
Net Debt ¹	2,578	683	5,888	3,921	2,471	4,937	2,420	-652.2
Reference price ²	239.92	276.92	258.77	152.92	175.99	228.69	228.69	228.69
Nbr of stocks (in thousands)	146,893	144,001	144,898	145,719	146,702	147,754	-	-
Announcement Date	2/3/22	2/15/23	2/13/24	2/12/25	2/6/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MODERNA, INC.	-23.72x	36.06x	-23.41x	-.--%	79.4B
REGENERON PHARMACEUTICALS, INC.	17.96x	4.21x	9.93x	0.5%	78.69B
CSL LIMITED	20.46x	4.36x	13.5x	2.42%	59.52B
UCB	21.44x	4.75x	13.52x	0.68%	46.58B
SAMSUNG BIOLOGICS CO.,LTD.	33.28x	11.32x	21.7x	-.--%	46.53B
BIOGEN INC.	37.12x	3.69x	13.85x	-.--%	33.63B
INCYTE CORPORATION	55.29x	3.51x	27.23x	-.--%	25.11B
INNOVENT BIOLOGICS, INC.	63.28x	7.06x	42.21x	-.--%	22.13B
SWEDISH ORPHAN BIOVITRUM AB	22.86x	4.91x	12.8x	-.--%	15.31B
Average	27.55x	8.88x	14.59x	0.4%	45.21B
Weighted average by Cap.	18.88x	11.42x	8.96x	0.53%